![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Klings E.S. Farber H.W.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.61, Iss.13, 2001-01, pp. : 1945-1956
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Medical management of primary pulmonary hypertension
Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 2, 2002-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Primary Pulmonary Hypertension
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 3, 2002-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Recognition and Management of Pulmonary Hypertension
Drugs, Vol. 56, Iss. 6, 1998-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drug Therapy of Primary Pulmonary Hypertension
American Journal of Cardiovascular Drugs, Vol. 4, Iss. 2, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Primary Antiphospholipid Syndrome and Pulmonary Hypertension
Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. :